| Literature DB >> 21151618 |
Karin Sadoul1, Jin Wang, Boubou Diagouraga, Saadi Khochbin.
Abstract
Reversible posttranslational modification of internal lysines in many cellular or viral proteins is now emerging as part of critical signalling processes controlling a variety of cellular functions beyond chromatin and transcription. This paper aims at demonstrating the role of lysine acetylation in the cytoplasm driving and coordinating key events such as cytoskeleton dynamics, intracellular trafficking, vesicle fusion, metabolism, and stress response.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21151618 PMCID: PMC2997609 DOI: 10.1155/2011/970382
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Lysine (K) acetyltransferases.
| New Name | Former name human | Former name D. melanogaster | Former name S. cerevisiae | Former name S. pombe | HAT complexes |
|---|---|---|---|---|---|
| GNAT family | |||||
| KAT1 | HAT1 | CG2051 | Hat1 | Hat1/Hag603 | HAT-B |
| KAT2 | dGCN5/PCAF | Gcn5 | Gcn5 | SAGA, ADA, ATAC | |
| KAT2A | hGCN5 | STAGA, TFTC | |||
| KAT2B | PCAF | PCAF complex | |||
| KAT9 | ELP3 | dELP3/CG15433 | Elp3 | Elp3 | Elongator for RNA polymerase II |
| HsMEC-17 | |||||
| p300/CBP family | |||||
| KAT3 | dCBP/NEJ | ||||
| KAT3A | CBP | ||||
| KAT3B | P300 | ||||
| MYST family | |||||
| KAT5 | TIP60/PLIP | dTIP60 | Esa1 | Mst1 | NuA4 |
| KAT6 | (CG1894) | Sas3 | (Mst2) | NuA3 | |
| KAT6A | MOZ/MYST3 | ||||
| KAT6B | MORF/MYST4 | ||||
| KAT7 | HBO1/MYST2 | (Mst2) | |||
| KAT8 | hMOF/MYST1 | dMOF (CG1894) | Sas2 | (Mst2) | MSL complex |
| nuclear receptor coactivators | |||||
| KAT13A | SRC-1 | ||||
| KAT13B | ACTR | ||||
| SRC-3 | |||||
| TIF-2 | |||||
| GRIP1 | |||||
| ATF-2 | |||||
| Divers | |||||
| KAT4 | TAF1 (TAFII250) | dTAF1 | Taf1 | Taf1 | TFIID |
| KAT10 | Hap2 | ||||
| KAT11 | Rtt109 | ||||
| KAT12 | TFIIIC90 | ||||
| KAT13C | P160 | ||||
| KAT13D | CLOCK | ||||
Lysine (K) deacetylases.
| Name | Localisation | Cytoplasmic substrates |
|---|---|---|
| Class I | ||
| HDAC1 | mainly nucleus | |
| HDAC2 | nucleus | |
| HDAC3 | mainly nucleus/cytoplasm | |
| HDAC8 | mainly cytoplasm | |
| class IIa | ||
| HDAC4 | cytoplasm/nucleus | MLP, DNAJB8 |
| HDAC5 | cytoplasm/nucleus | |
| HDAC7 | cytoplasm/mitochondria/nucleus | |
| HDAC9 | cytoplasm/nucleus | |
| Class IIb | ||
| HDAC6 | cytoplasm | tubulin, cortactin, Hsp90, |
| HDAC10 | cytoplasm/nucleus | |
| Class IV | ||
| HDAC11 | mainly nucleus | |
| Class III(sirtuins) | ||
| sirt1 | cytoplasm/nucleus | cortactin, Atg5, Atg7, Atg8 |
| sirt2 | cytoplasm | tubulin, cortactin? |
| sirt3 | mitochondria/long form cytoplasm | |
| sirt4 | mitochondria | |
| sirt5 | mitochondria | |
| sirt6 | nucleus | |
| sirt7 | nucleus | |
Figure 1Schematic overview of cytoplasmic mechanisms regulated by acetylation. (a) Localisation of acetylation events within a cell. Indicated are individual acetylated proteins and cytoskeletal structures (cortical actin and actin stress fibers, microtubules, intermediate filaments) as well as organelles (nucleus, mitochondria, ER, ERGIC, golgi) in which acetylation and deacetylation events take place. (b) Involvement of reversible acetylation in the regulation of various cytoplasmic processes, including cell migration following cytoskeleton remodelling, individual protein transport as well as vesicular transport and nucleocytoplasmic shuttling of proteins. (c) Regulation of stress response and cytoplasmic cleanup systems by various acetylation/deacetylation events.